Medicare Enrolled
Dr. Vince Rogenes, M.D.
Urology Physician · Plano, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rogenes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rogenes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rogenes
Dr. Vince Rogenes is an urology physician in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rogenes performed 3,367 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rogenes received a total of $4,349 from 48 pharmaceutical and/or device companies across 204 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rogenes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 35% volume in TX
$4,349 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,367
Medicare services
Top 35% in TX for urology physician
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
819 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
504 | $85 | $150 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
416 | $34 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $65 | $105 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
155 | $34 | $80 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
151 | $8 | $100 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 144 | $130 | $882 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
72 | $176 | $425 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $110 | $245 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $61 | $132 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $133 | $300 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
53 | $21 | $75 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
44 | $38 | $153 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
37 | $17 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $133 | $223 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $69 | $180 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
32 | $58 | $250 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
32 | $34 | $80 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
32 | $34 | $80 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
32 | $34 | $80 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
32 | $34 | $80 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $100 | $250 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
28 | $69 | $150 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $26 | $57 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
20 | $34 | $80 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $310 | $4,000 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
16 | $551 | $2,300 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
14 | $73 | $2,200 |
| New patient office visit, complex (60-74 min) | 14 | $163 | $295 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $89 | $450 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $23 | $275 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $21 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
6.1% medium
93.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,349
Total received (2018-2024)
Avg $621/year across 7 years
Top 41% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
204
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$475
2023
$372
2022
$876
2021
$841
2020
$362
2019
$773
2018
$650
Payments by company (2024)
PROCEPT BioRobotics Corporation
$180
ABBVIE INC.
$110
Sumitomo Pharma America, Inc.
$69
Dendreon Pharmaceuticals LLC
$29
Ferring Pharmaceuticals Inc.
$25
Endo Pharmaceuticals Inc.
$24
STERIS CORPORATION
$20
BIOPROTECT MEDICAL, INC.
$18
Top 3 companies account for 75.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$833
Boston Scientific Corporation
$393
ABBVIE INC.
$348
PFIZER INC.
$321
AbbVie Inc.
$276
PROCEPT BioRobotics Corporation
$218
Endo Pharmaceuticals Inc.
$139
AstraZeneca Pharmaceuticals LP
$132
Agiliti Surgical, Inc.
$129
AbbVie, Inc.
$106
Antares Pharma, Inc.
$104
Sumitomo Pharma America, Inc.
$96
Ferring Pharmaceuticals Inc.
$94
Coloplast Corp
$93
Axonics, Inc.
$73
BioTissue Holdings, Inc.
$70
BOSTON SCIENTIFIC CORPORATION
$65
Medtronic, Inc.
$60
Myovant Sciences Inc.
$48
Dendreon Pharmaceuticals LLC
$43
Teleflex LLC
$42
Allergan, Inc.
$42
COLOPLAST CORP
$39
Retrophin, Inc.
$38
Merck Sharp & Dohme Corporation
$37
Hollister Incorporated
$33
BIOTISSUE HOLDINGS, INC.
$33
Olympus America Inc.
$33
Accord Healthcare, Inc.
$32
Baxter Healthcare
$31
Bayer HealthCare Pharmaceuticals Inc.
$31
Allergan Inc.
$24
Photocure Inc
$23
Merck Sharp & Dohme LLC
$23
TISSUETECH, INC.
$23
Augmenix, Inc.
$22
Amgen Inc.
$20
STERIS CORPORATION
$20
Rochester Medical Corporation
$18
BIOPROTECT MEDICAL, INC.
$18
Acerus Pharmaceuticals Corporation
$18
Avadel Specialty Pharmaceuticals, LLC
$17
Palette Life Sciences, Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Novartis Pharmaceuticals Corporation
$16
KARL STORZ Endoscopy-America
$15
Integra LifeSciences Corporation
$13
Janssen Biotech, Inc.
$13
Top 3 companies account for 36.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 8.5 FR. X 700MM · ADSTILADRIN · ADVANCE · ADVANTAGE FIT · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · BIOFIX · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CMOS VIDEO URETEROSCOPE · CYSVIEW · Coloplast TFL Drive · Erleada · FIRMAGON · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GREENLIGHT · General - Kidney Stone Disease · INTERSTIM · ImaJin · Infyna Chic · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Ligation Solutions: Weck & Horizon brands · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NATPARA (PARATHYROID HORMONE) · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Olympus Ureteroscopes · Otrexup · PLUVICTO · PROVENGE · Porges Coloplast · Prolia · REZUM · SPEEDICATH · SpaceOAR · TISSEEL · TOVIAZ · Titan · UPHOLD LITE · UROLIFT · Uretero1 · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
132
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rogenes is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rogenes experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Rogenes performed 819 urinalysis, manual services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rogenes receive payments from pharmaceutical companies?
Yes. Dr. Rogenes received a total of $4,349 from 48 companies across 204 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rogenes's costs compare to other urology physicians in Plano?
Dr. Rogenes's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rogenes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plano
Browse urology physicians in Plano ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology